Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
93.71 CHF | +0.69% | +4.39% | +10.43% |
May. 13 | Legend Biotech 1Q Loss Narrows with Higher Carvykti Sales | DJ |
May. 10 | Novartis’ Scemblix Gets Third US FDA Breakthrough Therapy Designation | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.43% | 209B | |
+29.18% | 682B | |
+29.69% | 586B | |
-3.34% | 364B | |
+18.01% | 327B | |
+3.81% | 285B | |
+15.98% | 240B | |
-8.38% | 203B | |
+7.63% | 165B | |
-1.27% | 161B |
- Stock Market
- Equities
- NOVN Stock
- News Novartis AG
- Morgan Stanley Lifts Price Target on Novartis, Maintains Equalweight/In-Line Recommendation